157 related articles for article (PubMed ID: 17292773)
21. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
22. Bazex acrokeratosis as a paraneoplastic syndrome.
Villares-Soriano J; Vázquez-Barro C; Martínez-Vidal J
Acta Otorrinolaringol Esp; 2014; 65(2):138-9. PubMed ID: 23294970
[No Abstract] [Full Text] [Related]
23. Bazex's acrokeratosis paraneoplastica.
Laccourreye O; Laccourreye L; Jouffre V; Brasnu D
Ann Otol Rhinol Laryngol; 1996 Jun; 105(6):487-9. PubMed ID: 8638903
[No Abstract] [Full Text] [Related]
24. Bazex syndrome: acrokeratosis paraneoplastica.
Bolognia JL
Semin Dermatol; 1995 Jun; 14(2):84-9. PubMed ID: 7640201
[TBL] [Abstract][Full Text] [Related]
25. [Pathogenesis of acrokeratosis Bazex].
Hagedorn M; Stengel R
Dermatologica; 1983; 167(5):234-42. PubMed ID: 6653848
[TBL] [Abstract][Full Text] [Related]
26. [Randomized trial of combined chemotherapy including high dose cisplatin and radiotherapy for esophageal cancer].
Zhou JC
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):291-4. PubMed ID: 1725280
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous paraneoplastic syndrome (acrokeratosis paraneoplastica) preceding squamous cell carcinoma of the glottic larynx.
Aksu G; Karadeniz A
N Z Med J; 2006 Jun; 119(1235):U2006. PubMed ID: 16751829
[TBL] [Abstract][Full Text] [Related]
28. Bazex syndrome (paraneoplastic acrokeratosis).
Khachemoune A; Yalamanchili R; Rodriguez C
Cutis; 2004 Nov; 74(5):289-92. PubMed ID: 15605965
[TBL] [Abstract][Full Text] [Related]
29. [A case of locally advanced esophageal cancer effectively treated with concurrent chemotherapy and radiotherapy].
Segawa Y; Ohnoshi T; Ueoka H; Kiura K; Horiguchi T; Kodani T; Kamei H; Tabata M; Shibayama T; Maeda T
Gan To Kagaku Ryoho; 1992 Apr; 19(4):529-32. PubMed ID: 1373050
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
[TBL] [Abstract][Full Text] [Related]
31. Bullous lesions in Bazex syndrome and successful treatment with oral psoralen phototherapy.
Gill D; Fergin P; Kelly J
Australas J Dermatol; 2001 Nov; 42(4):278-80. PubMed ID: 11903162
[TBL] [Abstract][Full Text] [Related]
32. Bazex syndrome (acrokeratosis paraneoplastica): persistence of cutaneous lesions after successful treatment of an associated oropharyngeal neoplasm.
Fasanmade A; Farrell K; Perkins CS
Br J Oral Maxillofac Surg; 2009 Mar; 47(2):138-9. PubMed ID: 18775590
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic cutaneous leukocytoclastic vasculitis and iron deficiency anemia as the presenting features of squamous cell lung carcinoma.
Kathula SK; Thomas DE; Anstadt MP; Khan AU
J Clin Oncol; 2011 Feb; 29(4):e83-5. PubMed ID: 21098328
[No Abstract] [Full Text] [Related]
34. Treatment strategy for superficial pharyngeal squamous cell carcinoma synchronously combined with esophageal cancer.
Kaneko K; Yano T; Minashi K; Kojima T; Ito M; Satake H; Yajima Y; Yoda Y; Ikematsu H; Oono Y; Hayashi R; Onozawa M; Ohtsu A
Oncology; 2013; 84(1):57-64. PubMed ID: 23128894
[TBL] [Abstract][Full Text] [Related]
35. [Concomitant radiotherapy and chemotherapy with protracted low dose continuous infusion of 5-fluorouracil and cisplatin].
Sueyama H; Sakai K; Hasegawa M; Tsuchida E; Ito T; Sugita T; Higuchi S; Fujita K
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2839-41. PubMed ID: 7993125
[No Abstract] [Full Text] [Related]
36. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
[TBL] [Abstract][Full Text] [Related]
37. Chemoradiation for esophageal cancer: institutional experience with three different regimens.
Courrech Staal EF; Aleman BM; van Velthuysen ML; Cats A; Boot H; Jansen EP; van Coevorden F; van Sandick JW
Am J Clin Oncol; 2011 Aug; 34(4):343-9. PubMed ID: 20562589
[TBL] [Abstract][Full Text] [Related]
38. Bazex's syndrome (acrokeratosis paraneoplastica)--first case report of association with a bladder carcinoma.
Arregui MA; Ratón JA; Landa N; Izu R; Eizaquirre X; Díaz-Pérez JL
Clin Exp Dermatol; 1993 Sep; 18(5):445-8. PubMed ID: 8252768
[TBL] [Abstract][Full Text] [Related]
39. Amyopathic dermatomyositis associated with esophageal cancer.
Kikuchi K; Seto Y; Matsubara T; Yamada K; Tamaki K
Int J Dermatol; 2008 Mar; 47(3):310-1. PubMed ID: 18289345
[No Abstract] [Full Text] [Related]
40. Paraneoplastic acrokeratosis: Bazex syndrome.
Boudoulas O; Camisa C
Cutis; 1986 Jun; 37(6):449-53. PubMed ID: 3720352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
